SCHEMBL7834692

SCHEMBL7834692

O=C(O)CC(NC(=O)CNC(=O)c1cccc(NC(=O)Nc2ccccc2)c1)c1ccc2c(c1)OCO2

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 7/20 0.54
ITGA2B P08514 6/20 0.54
NPC1 O15118 5/20 0.51
RAB9A P51151 5/20 0.51
PAX8 Q06710 1/20 0.51
KLF5 Q13887 1/20 0.51
ITGAV P06756 2/20 0.51
MAPT P10636 1/20 0.48
HSD17B10 Q99714 2/20 0.48
POLB P06746 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
PKM P14618 1/20 0.47
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783235 0.92 ITGB3 (0.60) ITGB3ITGA2BNPC1RAB9AITGAV
SCHEMBL6777052 0.90 ITGB3 (0.59) ITGB3ITGA2BNPC1RAB9AITGAV
SCHEMBL27484811 0.85 ITGB3 (0.52) ITGB3ITGA2BITGAVHSD17B10MEN1
SCHEMBL6778762 0.83 ITGB3 (0.51) ITGB3NPC1RAB9AITGAVMAPT
SCHEMBL6779011 0.82 ALDH1A1 (0.59) ITGB3ITGA2BNPC1RAB9AMAPT
SCHEMBL6352863 0.82 ITGB3 (0.74) ITGB3ITGA2BNPC1RAB9AITGAV
SCHEMBL7338950 0.82 HSD17B10 (0.56) NPC1RAB9APAX8KLF5MAPT
SCHEMBL6776927 0.81 ITGB3 (0.47) ITGB3ITGA2BITGAV
SCHEMBL27561813 0.80 ITGB3 (0.46) ITGB3ITGA2BITGAVSMN1; SMN2ALDH1A1
SCHEMBL6778483 0.79 SUCNR1 (0.53) ITGB3ITGA2BITGAVALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP claimed
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed